BioStem Technologies, Inc.
BSEMHealthcare|Biotechnology|US
$1.13
+0.09 (+8.65%)
Tangible Book / Share
$0.27
Cash / Share
$0.40
Financials
Financial Snapshot
Market Cap
$21.1M
Enterprise Value
$15.4M
Revenue (TTM)
-$60.3M
Net Income (TTM)
-$28.3M
Cash & Investments
$7.0M
Net Cash
$5.7M
Free Cash Flow (TTM)
-$8.8M
Operating CF (TTM)
-$5.9M
Debt/Equity
0.04
Cash Runway & Burn Rate
Cash on Hand
$7.0M
Quarterly Burn
$1.5M
Monthly Burn
$493.3K
Est. Runway
~4.7 quarters
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $171.3K | $47.9K | $1.2M | $140.7K | $100.7K | $340.3K | $772.1K | $239.4K | $22.8M | $29.5M | $7.0M | |
| Operating Cash Flow | -$1.6M | -$1.9M | -$3.7M | -$845.8K | -$581.6K | -$109.4K | $303.6K | -$3.5M | $24.5M | $9.9M | -$5.9M | |
| Free Cash Flow | -$2.6M | -$2.0M | -$3.9M | -$979.4K | -$585.3K | -$152.3K | -$165.9K | -$3.7M | $24.1M | $6.6M | -$8.8M | |
| Capital Expenditure | -$988.2K | -$156.3K | -$198.8K | -$133.6K | -$3.7K | -$42.8K | -$469.5K | -$210.3K | -$426.6K | -$3.4M | -$2.9M | |
| Financing Cash Flow | $2.2M | $1.9M | $5.1M | -$235.0K | $541.5K | $357.4K | $597.7K | $3.2M | -$206.8K | -$1.1M | -$1.3M |
R&D Spending
R&D (TTM)
$5.3M
R&D Intensity
—
R&D Growth vs Prior
-25.1%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $592.3K | $328.5K | $1.0M | $2.6M | $2.5M | $4.3M | $6.9M | $16.7M | $301.8M | $47.5M | -$60.3M | |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $119.6K | $224.8K | $342.0K | $1.9M | $7.1M | $5.3M | |
| R&D % of Revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.8% | 3.3% | 2.0% | 0.6% | 14.9% | -8.8% | |
| SG&A | $3.6M | $5.0M | $8.2M | $7.0M | $3.1M | $4.2M | $10.2M | $22.6M | $254.7M | $37.8M | -$50.6M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $592.3K | $328.5K | $1.0M | $2.6M | $2.5M | $4.3M | $6.9M | $16.7M | $301.8M | $47.5M | -$60.3M | |
| Cost of Revenue | $359.5K | $149.7K | $602.0K | $1.3M | $1.3M | $1.5M | $881.8K | $1.3M | $13.7M | $3.3M | $8.4M | |
| Gross Profit | $232.8K | $178.9K | $415.2K | $1.3M | $1.3M | $2.9M | $6.0M | $15.4M | $288.1M | $44.2M | -$68.7M | |
| R&D | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $119.6K | $224.8K | $342.0K | $1.9M | $7.1M | $5.3M | |
| SG&A | $3.6M | $5.0M | $8.2M | $7.0M | $3.1M | $4.2M | $10.2M | $22.6M | $254.7M | $37.8M | -$50.6M | |
| Operating Income | -$3.4M | -$4.8M | -$7.8M | -$5.7M | -$1.8M | -$1.6M | -$4.7M | -$7.8M | $31.2M | -$689.1K | -$23.3M | |
| Interest Expense | $50.2K | $33.8K | $256.0K | $633.0K | $530.9K | $525.9K | $468.2K | $700.3K | $587.2K | $0.00 | $0.00 | |
| Pretax Income | -$3.6M | -$4.9M | -$7.7M | -$6.3M | -$2.4M | -$1.4M | -$7.2M | -$8.5M | $30.6M | -$389.6K | -$23.6M | |
| Net Income | -$3.6M | -$4.8M | -$7.6M | -$6.4M | -$2.4M | -$1.4M | -$7.2M | -$8.5M | $31.9M | -$6.6M | -$28.3M | |
| EPS (Diluted) | -1.07 | -0.95 | -0.94 | -0.69 | -0.26 | -0.15 | -0.63 | -0.62 | 1.47 | -0.39 | -1.68 | |
| EBITDA | -$3.0M | -$4.6M | -$7.3M | -$5.4M | -$1.6M | -$602.1K | -$6.5M | -$7.6M | $31.5M | -$308.1K | -$21.8M | |
| Shares Out. (M) | 3.33 | 5.07 | 8.11 | 9.25 | 9.18 | 9.32 | 11.40 | 13.71 | 21.70 | 16.73 | 17.33 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $171.3K | $47.9K | $1.2M | $140.7K | $100.7K | $340.3K | $772.1K | $239.4K | $22.8M | $29.5M | $7.0M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $2.1M | $251.7K | $2.0M | $1.1M | $851.0K | $938.6K | $1.5M | $12.6M | $133.8M | $44.4M | $20.8M | |
| Total Assets | $5.8M | $3.0M | $4.3M | $3.2M | $2.7M | $2.7M | $3.5M | $14.6M | $140.4M | $50.0M | $48.8M | |
| Total Current Liabilities | $2.4M | $1.6M | $5.2M | $5.9M | $6.8M | $6.5M | $6.3M | $15.6M | $99.2M | $10.8M | $21.2M | |
| Long-Term Debt | $500.0K | $500.0K | $467.9K | $914.3K | $1.3M | $1.8M | $1.0M | $265.6K | $150.0K | $0.00 | $0.00 | |
| Total Liabilities | $2.4M | $1.6M | $6.0M | $7.1M | $8.3M | $8.5M | $7.4M | $15.9M | $99.5M | $10.9M | $21.2M | |
| Stockholders' Equity | $3.4M | $1.5M | -$1.6M | -$4.1M | -$5.8M | -$6.0M | -$4.1M | -$1.3M | $40.9M | $39.1M | $27.6M | |
| Retained Earnings | -$6.2M | -$10.7M | -$19.3M | -$25.9M | -$28.2M | -$29.9M | -$37.1M | -$45.6M | -$13.7M | -$21.2M | -$39.0M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.6M | -$1.9M | -$3.7M | -$845.8K | -$581.6K | -$109.4K | $303.6K | -$3.5M | $24.5M | $9.9M | -$5.9M | |
| Capital Expenditure | -$988.2K | -$156.3K | -$198.8K | -$133.6K | -$3.7K | -$42.8K | -$469.5K | -$210.3K | -$426.6K | -$3.4M | -$2.9M | |
| Free Cash Flow | -$2.6M | -$2.0M | -$3.9M | -$979.4K | -$585.3K | -$152.3K | -$165.9K | -$3.7M | $24.1M | $6.6M | -$8.8M | |
| Investing Cash Flow | -$764.8K | -$156.3K | -$268.8K | $45.4K | -$3.7K | -$7.8K | -$469.5K | -$210.3K | -$1.7M | -$2.1M | -$16.7M | |
| Financing Cash Flow | $2.2M | $1.9M | $5.1M | -$235.0K | $541.5K | $357.4K | $597.7K | $3.2M | -$206.8K | -$1.1M | -$1.3M | |
| Issuance of Stock | $1.6M | $1.6M | $1.2M | $0.00 | $186.0K | $125.0K | $50.0K | $0.00 | $642.6K | $48.3K | $2.4M | |
| Repurchase of Stock | $0.00 | $0.00 | -$33.3K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $400.0K | $55.0K | $4.0M | -$235.0K | $541.5K | $232.4K | $547.7K | $797.1K | -$849.4K | -$1.2M | -$3.6M | |
| Stock Based Comp. | $1.3M | $1.2M | $0.00 | $0.00 | $0.00 | $403.0K | $4.9M | $5.8M | $0.00 | $0.00 | $3.9M | |
| Net Change in Cash | -$240.6K | -$128.3K | $1.1M | -$1.0M | -$40.0K | $240.1K | $431.8K | -$532.7K | $22.6M | $6.7M | -$23.9M |
Dilution Tracker
Shares outstanding grew 82.3% over 5 years — significant dilution
Shares Outstanding
19M
5-Year Share Growth
+82.3%
Stock Issuance (TTM)
$2.4M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 3.33 | 5.07 | 8.11 | 9.25 | 9.18 | 9.32 | 11.40 | 13.71 | 21.70 | 16.73 | 17.33 | |
| Change vs Prior % | — | 52.4% | 59.8% | 14.1% | -0.8% | 1.6% | 22.4% | 20.2% | 58.3% | -22.9% | 3.6% | |
| Stock Issuance | $1.6M | $1.6M | $1.2M | $0.00 | $186.0K | $125.0K | $50.0K | $0.00 | $642.6K | $48.3K | $2.4M | |
| Stock Repurchase | $0.00 | $0.00 | -$33.3K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $1.3M | $1.2M | $0.00 | $0.00 | $0.00 | $403.0K | $4.9M | $5.8M | $0.00 | $0.00 | $3.9M |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 39.3% | 54.4% | 40.8% | 49.8% | 49.6% | 66.0% | 87.2% | 92.4% | 95.4% | 93.1% | 113.9% | |
| Operating Margin % | -571.3% | -1470.2% | -763.6% | -217.8% | -73.1% | -37.0% | -68.1% | -46.6% | 10.3% | -1.5% | 38.7% | |
| Net Margin % | -601.5% | -1473.7% | -746.7% | -242.7% | -94.7% | -33.3% | -104.6% | -50.8% | 10.6% | -13.9% | 46.9% | |
| EBITDA Margin % | -504.9% | -1398.4% | -715.6% | -204.6% | -63.2% | -13.9% | -95.1% | -45.3% | 10.4% | -0.6% | 36.1% | |
| FCF Margin % | -443.5% | -621.4% | -379.4% | -37.2% | -23.2% | -3.5% | -2.4% | -22.2% | 8.0% | 13.9% | 14.6% | |
| ROE % | -104.5% | -325.2% | 471.5% | 156.2% | 41.2% | 24.3% | 176.5% | 631.0% | 78.0% | -16.8% | -76.1% | |
| ROA % | -61.3% | -159.6% | -176.6% | -202.4% | -89.5% | -54.1% | -207.5% | -58.3% | 22.7% | -13.2% | -58.0% | |
| ROIC % | -78.6% | -246.0% | -220.2% | -486.4% | 23838.8% | 190.5% | -393.5% | -229.2% | 68.9% | -1.6% | -80.9% | |
| R&D / Revenue % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.8% | 3.3% | 2.0% | 0.6% | 14.9% | -8.8% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 290.9% | -44.5% | 209.6% | 158.6% | -4.1% | 72.1% | 58.4% | 142.7% | 1708.9% | -84.3% | |
| Gross Profit | 175.2% | -23.2% | 132.1% | 215.7% | -4.5% | 128.9% | 109.1% | 157.3% | 1767.8% | -84.7% | |
| Operating Income | -43.3% | -42.7% | -60.8% | 26.2% | 67.8% | 12.8% | -191.6% | -66.2% | 501.1% | -102.2% | |
| Net Income | -49.7% | -35.9% | -56.9% | 15.9% | 62.6% | 39.5% | -397.7% | -17.9% | 475.9% | -120.6% | |
| EPS (Diluted) | 47.8% | 11.2% | 1.1% | 26.6% | 62.3% | 42.3% | -320.0% | 1.6% | 337.1% | -126.5% | |
| Operating Cash Flow | -363.5% | -15.0% | -94.2% | 76.9% | 31.2% | 81.2% | 377.4% | -1252.6% | 799.5% | -59.4% | |
| Free Cash Flow | -23.0% | 22.3% | -89.0% | 74.6% | 40.2% | 74.0% | -8.9% | -2135.7% | 748.4% | -72.6% | |
| R&D Expense | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 87.9% | 52.2% | 458.8% | 270.8% | |
| SG&A Expense | 47.9% | 38.5% | 63.4% | -14.0% | -56.1% | 35.3% | 143.7% | 121.7% | 1025.6% | -85.2% | |
| Total Assets | 97.9% | -47.8% | 41.8% | -26.7% | -15.4% | 0.1% | 29.8% | 320.0% | 864.1% | -64.4% | |
| Book Value / Share | -27.6% | -71.8% | -171.5% | -106.2% | -44.3% | -1.3% | 44.3% | 71.7% | 2646.1% | -6.3% | |
| Debt | 80.0% | 6.1% | 444.5% | -1.7% | 10.0% | -14.1% | 5.3% | -7.2% | -7.0% | -24.2% | |
| Diluted Shares | 186.0% | 52.4% | 59.8% | 14.1% | -0.8% | 1.6% | 22.4% | 20.2% | 58.3% | -22.9% |
Valuation
P/E (TTM)At Loss
P/S-0.35
10Y Low / Med / High0.75 / 5.28 / 185.28
P/B0.71
10Y Low / Med / High1.63 / 9.81 / 40.88
EV/EBITDAAt Loss
EV/Revenue-0.25
10Y Low / Med / High0.69 / 7.47 / 188.04
P/FCFAt Loss
Intrinsic Value Models (per share)
Tangible Book / Share
$0.27
Cash / Share
$0.40
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -9.39 | -12.63 | -3.40 | -3.62 | -5.58 | -6.93 | -4.75 | -9.45 | 7.10 | -9.77 | -0.68 | |
| P/S Ratio | 56.47 | 185.28 | 25.50 | 8.79 | 5.28 | 2.23 | 4.96 | 4.81 | 0.75 | 1.34 | -0.35 | |
| P/B Ratio | 9.81 | 40.88 | -16.11 | -5.66 | -2.29 | -1.63 | -8.37 | -59.75 | 5.54 | 1.63 | 0.71 | |
| EV/EBITDA | -11.43 | -13.45 | -4.12 | -5.22 | -11.81 | -23.56 | -5.87 | -11.23 | 6.61 | -121.76 | -0.71 | |
| EV/Revenue | 57.70 | 188.04 | 29.46 | 10.68 | 7.47 | 3.27 | 5.59 | 5.08 | 0.69 | 0.79 | -0.25 |
Analyst Estimates & Quality
Altman Z-Score
-3.34
Distress
Piotroski F-Score
2
Weak
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
| Revenue | $28.7M | $53.9M | $84.8M |
| Net Income | -$31.8M | -$17.4M | -$1.5M |
| EPS | $-1.90 | $-1.04 | $-0.09 |
| # Analysts (EPS) | 1 | 1 | 1 |